XML 24 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
Compensatory Equity Incentive Plan and Other Equity Incentives
6 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Compensatory Equity Incentive Plan and Other Equity Incentives

6. Compensatory Equity Incentive Plan and Other Equity Incentives

Share-Based Compensation Arrangements—The Plan includes several available forms of stock compensation of which incentive stock options and restricted stock awards have been granted to date.

The 2004 Employee Stock Purchase Plan (“ESPP”) permitted employees to purchase common stock through payroll deductions, not to exceed 15% of an employee’s compensation, at a price not less than 85% of the market value of the stock on specified dates (June 30 and December 31). In no event could any participant purchase more than $25,000 worth of shares of Class A common stock in any calendar year and an employee could purchase no more than 4,000 shares on any purchase date within an offering period of 12 months and 2,000 shares on any purchase date within an offering period of six months. The ESPP expired on December 6, 2014, and was replaced by the LightPath Technologies, Inc. Employee Stock Purchase Plan (“2014 ESPP”), which was adopted by our board of directors on October 30, 2014 and approved by our stockholders on January 29, 2015.

The 2014 ESPP permits employees to purchase common stock through payroll deductions, which may not exceed 15% of an employee’s compensation, at a price not less than 85% of the market value of the stock on specified dates (June 30 and December 31). In no event can any participant purchase more than $25,000 worth of shares of Class A common stock in any calendar year and an employee cannot purchase more than 8,000 shares on any purchase date within an offering period of 12 months and 4,000 shares on any purchase date within an offering period of six months. A discount of $846 and $1,356 for the six months ended December 31, 2015 and 2014, respectively, is included in the selling, general and administrative expense in the accompanying consolidated statements of comprehensive income (loss), which represents the value of the 10% discount given to the employees purchasing stock under the 2014 Plan.

These plans are summarized below:

      Award Shares  Available for
     Outstanding  Issuance
   Award Shares   at December 31,  at December 31,
Equity Compensation Arrangement  Authorized  2015  2015
Amended and Restated Omnibus Incentive Plan   3,915,625    2,144,432    1,131,903 
Employee Stock Purchase Plan   400,000    —      395,298 
                
    4,315,625    2,144,432    1,527,201 

Grant Date Fair Values and Underlying Assumptions; Contractual Terms— We estimate the fair value of each stock option as of the date of grant. We use the Black-Scholes-Merton pricing model. The ESPP or the 2014 ESPP fair value is the amount of the discount the employee obtains at the date of the purchase transaction.

For stock options granted in the six month periods ended December 31, 2015 and 2014, we estimated the fair value of each stock option as of the date of grant using the following assumptions:

  Six months ended Six month ended
  December 31, 2015 December 31, 2014
Expected volatility 68% - 103% 103%
Weighted average expected volatility 68% - 103% 103%
Dividend yields 0% 0%
Risk-free interest rate 0.37% - 1.49% 1.77%
Expected term, in years 4.29 - 7.50 7.50

 

 

Most options granted under the Plan vest ratably over two to four years and are generally exercisable for ten years. The assumed forfeiture rates used in calculating the fair value of options and restricted stock unit grants with both performance and service conditions were 20% for each of the six months ended December 31, 2015 and 2014. The volatility rate and expected term are based on seven-year historical trends in Class A common stock closing prices and actual forfeitures. The interest rate used is the U.S. Treasury interest rate for constant maturities.

Information Regarding Current Share-Based Compensation Awards—A summary of the activity for share-based compensation awards in the six months ended December 31, 2015 is presented below:

            Restricted
   Stock Options  Stock Units (RSUs)
      Weighted  Weighted     Weighted
      Average  Average     Average
      Exercise  Remaining     Remaining
      Price  Contract     Contract
   Shares  (per share)  Life (YRS)  Shares  Life (YRS)
June 30, 2015   722,483   $2.08    5.3    1,075,300    0.9 
                          
Granted   150,592   $1.48    9.8    236,495    2.8 
Exercised   (2,700)  $1.05    3.0    —      —   
Cancelled/Forfeited   (37,738)  $2.76    —      —      —   
                          
December 31, 2015   832,637   $1.95    5.9    1,311,795    1.1 
                          
Awards exercisable/                         
vested as of                         
December 31, 2015   643,637   $2.13    5.2    803,526    —   
                          
Awards unexercisable/                         
unvested as of                         
December 31, 2015   189,000   $1.33    8.6    508,269    1.1 
    832,637              1,311,795      

The total intrinsic value of options outstanding and exercisable at December 31, 2015 and 2014 was $590,174 and $208, respectively.

The total intrinsic value of RSUs exercised during the six months ended December 31, 2015 and 2014 was $0 and $0, respectively.

The total intrinsic value of RSUs outstanding and exercisable at December 31, 2015 and 2014 was $2,273,979 and $550,155, respectively.

The total fair value of RSUs vested during the six months ended December 31, 2015 and 2014 was $183,101 and $156,660, respectively.

The total fair value of option shares vested during the six months ended December 31, 2015 and 2014 was $223,229 and $65,500, respectively.

 

As of December 31, 2015, there was $664,681 of total unrecognized compensation cost related to non-vested share-based compensation arrangements (including share options and restricted stock units) granted under the Plan. We expect to recognize the compensation cost as follows:

      Restricted   
      Stock   
   Stock  Share/   
   Options  Units  Total
          
 Six months ended June 30, 2016   $24,168   $149,896   $174,064 
                  
 Year ended June 30, 2017    41,429    237,187    278,616 
                  
 Year ended June 30, 2018    27,661    141,580    169,241 
                  
 Year ended June 30, 2019    11,923    29,153    41,076 
                  
 Year ended June 30, 2020    1,684    —      1,684 
     $106,865   $557,816   $664,681 

Restricted stock unit awards vest immediately or from two to four years from the date of grant.

We issue new shares of Class A common stock upon the exercise of stock options. The following table is a summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards as of December 31, 2015 and changes during the six months then ended:

Unexercisable/unvested awards  Stock
Options
Shares
  RSU
Shares
  Total
Shares
 

Weighted-Average

Grant Date Fair Values

(per share)

June 30, 2015   224,500    403,870    628,370   $1.23 
Granted   150,592    236,495    387,087   $1.39 
Vested   (186,092)   (132,096)   (318,188)  $1.28 
Cancelled/Forfeited   —      —      —      —   
December 31, 2015   189,000    508,269    697,269   $1.30 

Financial Statement Effects and Presentation—The following table shows total stock-based compensation expense for the six months ended December 31, 2015 and 2014 included in the consolidated statements of comprehensive income (loss):

 

   (Unaudited)  (Unaudited)
   Six months ended  Six months ended
   December 31,  December 31,
   2015  2014
       
 Stock options  $25,041   $27,106 
 RSU   149,546    110,969 
      Total  $174,587   $138,075 
           
 The amounts above were included in:          
 General & administrative  $173,662    133,042 
 Cost of sales   158    —   
 New product development   767    5,033 
   $174,587    138,075